| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/29/2002 | EP1208421A2 Methods for obtaining and using haplotype data |
| 05/29/2002 | EP1208384A2 Methods and compositions for modulating oxidized ldl transport |
| 05/29/2002 | EP1208381A2 Proteins, genes and their use for diagnosis and treatment of breast cancer |
| 05/29/2002 | EP1208380A2 Cancer associated antigens and uses therefor |
| 05/29/2002 | EP1208242A1 Antisense modulation of pepck-mitochondrial expression |
| 05/29/2002 | EP1208241A1 Method and kit for the detection of schistosomiasis through the polymerase chain reaction |
| 05/29/2002 | EP1208238A1 Methods of immobilizing ligands on solid supports and apparatus and methods of use therefor |
| 05/29/2002 | EP1208236A2 Template-dependent nucleic acid polymerization using oligonucleotide triphosphates building blocks |
| 05/29/2002 | EP1208235A1 Abc transport polynucleotides, polypeptides, and antibodies |
| 05/29/2002 | EP1208234A1 Poly(ether-thioether), poly(ether-sulfoxide) and poly(ether-sulfone) nucleic acids |
| 05/29/2002 | EP1208229A1 Methods and compositions for isolating high molecular weight dna from natural samples |
| 05/29/2002 | EP1208228A2 Differential gene expression in specific regions of the brain in neurodegenerative diseases |
| 05/29/2002 | EP1208226A2 Immobilization of unmodified biopolymers to acyl fluoride activated substrates |
| 05/29/2002 | EP1208225A2 Single nucleotide polymorphisms in mitochondrial genes that segregate with alzheimer's disease |
| 05/29/2002 | EP1208223A2 Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays |
| 05/29/2002 | EP1208222A2 Customized oligonucleotide microchips that convert multiple genetic information to simple patterns |
| 05/29/2002 | EP1208221A2 Screening for inhibitors of lumazine synthase |
| 05/29/2002 | EP1208219A1 Synthesis of biologically active compounds in cells |
| 05/29/2002 | EP1208218A2 Methods and compositions for delivery of pharmaceutical agents |
| 05/29/2002 | EP1208217A1 Antibody dependent enhancement (ade) of alphavirus infection |
| 05/29/2002 | EP1208216A2 Fatty acid desaturase gene from plants |
| 05/29/2002 | EP1208215A2 Plant defensin variants with modified cystein residues |
| 05/29/2002 | EP1208214A2 Genetically engineered bleb vaccine |
| 05/29/2002 | EP1208213A1 Method for production of proteins in host cells involving the use of chaperonins |
| 05/29/2002 | EP1208212A1 Fibrin sealant as a transfection/transformation vehicle for gene therapy |
| 05/29/2002 | EP1208211A1 Means and methods for modifying gene expression using unpolyadenylated rna |
| 05/29/2002 | EP1208210A2 Archaeal replication accessory factors and methods of use |
| 05/29/2002 | EP1208209A1 Evolution and use of enzymes for combination and medicinal chemistry |
| 05/29/2002 | EP1208208A2 Transgenic systems for the manufacture of poly(3-hydroxy -butyrate -co -3- hydroxyhexanoate) |
| 05/29/2002 | EP1208207A2 Method for producing a channel-forming protein |
| 05/29/2002 | EP1208206A2 Moraxella catarrhalis antigen basb121 |
| 05/29/2002 | EP1208205A2 Methods for producing l-amino acids by increasing cellular nadph |
| 05/29/2002 | EP1208204A2 Plant reproduction proteins |
| 05/29/2002 | EP1208203A2 Method for the production of calendic acid, a fatty acid containing delta-8,10,12 conjugated double bonds and dimorphecolic acid, a fatty acid containing a 9-hydroxy group and delta-10,12 conjugated double bonds |
| 05/29/2002 | EP1208202A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 05/29/2002 | EP1208201A2 Compositions and methods for the treatment of immune related diseases |
| 05/29/2002 | EP1208200A2 Transgenic animal model for neurodegenerative diseases |
| 05/29/2002 | EP1208199A2 DNA CODING FOR $g(b)-TUBULIN AND USE THEREOF |
| 05/29/2002 | EP1208198A2 Egfh2 genes and gene products |
| 05/29/2002 | EP1208197A1 Iren protein, its preparation and use |
| 05/29/2002 | EP1208196A1 15571, a novel gpcr-like molecule of the secretin-like family and uses thereof |
| 05/29/2002 | EP1208195A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 05/29/2002 | EP1208194A2 Drug target isogenes: polymorphisms in the immunoglobulin e receptor i alpha subunit gene |
| 05/29/2002 | EP1208193A1 Dna shuffling of dioxygenase genes for production of industrial chemicals |
| 05/29/2002 | EP1208192A1 Method for producing a heterologous secreted protein from chinese hamster ovary cells grown on microcarriers |
| 05/29/2002 | EP1208191A1 13 human colon and colon cancer associated proteins |
| 05/29/2002 | EP1208190A1 Rapid growing microorganisms for biotechnology applications |
| 05/29/2002 | EP1208160A1 Red-emitting 8,9]benzophenoxazine nucleic acid dyes and methods for their use |
| 05/29/2002 | EP1208133A1 Copolymers for the transfer of nucleic acids to the cell |
| 05/29/2002 | EP1208115A2 Feline interleukin-12 as an immune stimulant |
| 05/29/2002 | EP1208112A1 Drug target isogenes: polymorphisms in the 5-hydroxytryptamine receptor 1a gene |
| 05/29/2002 | EP1208111A2 Genes encoding insect odorant receptors and uses thereof |
| 05/29/2002 | EP1208110A1 Antisense modulation of focal adhesion kinase expression |
| 05/29/2002 | EP1208109A2 Nucleoside analogues |
| 05/29/2002 | EP1207959A1 Individually addressable micro-electromagnetic unit array chips |
| 05/29/2002 | EP1207958A1 Sensor for microfluid handling system |
| 05/29/2002 | EP1207955A1 Method and device for performing operations at charged microlocations |
| 05/29/2002 | EP1207895A1 Peptide and peptide analogues for the treatment and prevention of diabetes |
| 05/29/2002 | EP1207751A1 Non-mammalian transgenic animal model for cellular proliferative diseases |
| 05/29/2002 | EP1036082B1 Isolation of nucleic acids |
| 05/29/2002 | EP1021561A4 $g(b)-ADRENERGIC RECEPTOR POLYMORPHISMS |
| 05/29/2002 | EP1002095B1 Improved protein expression strains |
| 05/29/2002 | EP0981646A4 Enzymatic dna molecules |
| 05/29/2002 | EP0889971B1 Phosphatase modulator |
| 05/29/2002 | EP0752002B1 Inhibition of arterial smooth muscle cell proliferation |
| 05/29/2002 | EP0725137B1 Keto group introducing enzyme, dna coding for the same, and process for producing ketocarotenoid |
| 05/29/2002 | EP0603190B1 Plant-derived enzyme and dna sequences, and uses thereof |
| 05/29/2002 | EP0573544B1 Intestinal trefoil proteins |
| 05/29/2002 | DE10058319A1 Verfahren zur Selektion von Peptid-Liganden A method for the selection of peptide ligands |
| 05/29/2002 | DE10057014A1 Preparing target cell-specific pharmaceutical, useful for gene therapy of e.g. cancer, by cloning expression control sequences having higher activity in target cell |
| 05/29/2002 | DE10056899A1 New promoter from Saccharomyces cerevisiae YNL279W gene, useful e.g. for identifying modulators of G protein-coupled receptors, is responsive to pheromone alpha |
| 05/29/2002 | DE10056802A1 Verfahren zur Detektion von Methylierungszuständen zur toxikologischen Diagnostik A method for the detection of methylation states for diagnosis toxicological |
| 05/29/2002 | DE10056210A1 Virales Expressionssystem Viral expression system |
| 05/29/2002 | DE10055870A1 Neue für das nadC-Gen kodierende Nukleotidsequenzen New coding for the NADC gene nucleotide sequences |
| 05/29/2002 | DE10055383A1 Verwendung des humanen LRP/MVP Promotors für einen Therapie-induzierbaren Vektor Using the human LRP / MVP promoter for a therapy-inducible vector |
| 05/29/2002 | DE10046462A1 Verbesserte Verfahren zur Vitamin E Biosynthese Improved methods for vitamin E biosynthesis |
| 05/29/2002 | CN1351715A Use of genes of the deoxy-D-xylulose phosphate biosynthetic pathway for altering the concentration of isoprenoid |
| 05/29/2002 | CN1351713A Diagnosis and treatment of atherosclerosis and coronary heart disease |
| 05/29/2002 | CN1351712A Method for the identification and/or the quantification of a target compound |
| 05/29/2002 | CN1351672A Method for analysing a patient's genetic predisposition to at least a disease and amplification adapted to such a method |
| 05/29/2002 | CN1351671A Transposon-based genetic marker |
| 05/29/2002 | CN1351669A Chimeric promoters based on the plastocyanin PETE promoter from pea |
| 05/29/2002 | CN1351668A Improved method for agrobacterium mediated transformation of cotton |
| 05/29/2002 | CN1351667A Transgenic plants that are resistant to a broad specrum of pathogens |
| 05/29/2002 | CN1351666A Recombinant bacterial phytases and uses thereof |
| 05/29/2002 | CN1351665A Sorbitol dehydrogenase, gene encoding this same and thereof |
| 05/29/2002 | CN1351664A DNA sequence and recombination production of a graminae allergen |
| 05/29/2002 | CN1351663A Viral variants |
| 05/29/2002 | CN1351662A Inhibition of viral infection using monovalent antigen-binding proteins |
| 05/29/2002 | CN1351661A Compounds |
| 05/29/2002 | CN1351660A directed evolution of microorganisms |
| 05/29/2002 | CN1351659A 神经酰胺酶基因 Neuraminidase gene |
| 05/29/2002 | CN1351658A Subtilase enzymes of the 1-S1 and 1-S2 sub-groups having at least one additional amino acid residue between positions 97 and 98 |
| 05/29/2002 | CN1351657A Polypeptides having alkaline 2-amylase activity and nucleic acids encoding same |
| 05/29/2002 | CN1351656A Human liver progenitors |
| 05/29/2002 | CN1351653A Anti-bacterial vaccine compositions |
| 05/29/2002 | CN1351614A Human antibodies that bind human IL-12 and methods for producing |
| 05/29/2002 | CN1351613A Chemokine-like factors having cell chemokinesis function and proliferation-stimulating activity |
| 05/29/2002 | CN1351612A Novel organic anion transport proteins |
| 05/29/2002 | CN1351503A Vaccine against streptococcus pneumoniae |